25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biodesix Inc
Buy, Hold or Sell?

Let's analyze Biodesix together

I guess you are interested in Biodesix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biodesix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biodesix Inc

I send you an email if I find something interesting about Biodesix Inc.

1. Quick Overview

1.1. Quick analysis of Biodesix (30 sec.)










1.2. What can you expect buying and holding a share of Biodesix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
11.1%

What is your share worth?

Current worth
$0.19
Expected worth in 1 year
$0.39
How sure are you?
25.9%

+ What do you gain per year?

Total Gains per Share
$0.20
Return On Investment
15.0%

For what price can you sell your share?

Current Price per Share
$1.34
Expected price per share
$1.11 - $1.4714
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biodesix (5 min.)




Live pricePrice per Share (EOD)
$1.34
Intrinsic Value Per Share
$-3.27 - $-3.79
Total Value Per Share
$-3.08 - $-3.60

2.2. Growth of Biodesix (5 min.)




Is Biodesix growing?

Current yearPrevious yearGrowGrow %
How rich?$27.8m$4.1m$11.6m73.5%

How much money is Biodesix making?

Current yearPrevious yearGrowGrow %
Making money-$10.9m-$17m$6m55.7%
Net Profit Margin-67.7%-165.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Biodesix (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#88 / 136

Most Revenue
#85 / 136

Most Profit
#108 / 136
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biodesix?

Welcome investor! Biodesix's management wants to use your money to grow the business. In return you get a share of Biodesix.

First you should know what it really means to hold a share of Biodesix. And how you can make/lose money.

Speculation

The Price per Share of Biodesix is $1.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biodesix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biodesix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.19. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biodesix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-5.2%-0.08-5.6%-0.10-7.4%-0.08-5.9%-0.07-5.4%
Usd Book Value Change Per Share-0.06-4.4%0.053.7%0.000.2%0.010.7%0.010.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.3%0.000.1%0.000.1%
Usd Total Gains Per Share-0.06-4.4%0.053.7%0.010.5%0.010.8%0.010.6%
Usd Price Per Share1.78-1.65-1.76-4.27-3.16-
Price to Earnings Ratio-6.35--5.66--4.50--20.11--14.89-
Price-to-Total Gains Ratio-30.25--0.28-2.82--182.59--182.59-
Price to Book Ratio9.35-9.03--28.97-12.99-9.62-
Price-to-Total Gains Ratio-30.25--0.28-2.82--182.59--182.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.34
Number of shares746
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (746 shares)37.377.90
Gains per Year (746 shares)149.4731.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1014913932822
2029928865754
30448437108586
4059858613114118
5074773516142150
6089788419170182
701046103322199214
801196118226227246
901345133129256278
1001495148032284310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.027.00.00.0%0.027.00.00.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.012.01.035.0%7.012.08.025.9%7.012.08.025.9%
Dividend per Share0.00.04.00.0%3.00.09.025.0%3.00.017.015.0%3.00.024.011.1%3.00.024.011.1%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.012.01.035.0%7.012.08.025.9%7.012.08.025.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biodesix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0590.050-217%0.003-2450%0.010-718%0.007-934%
Book Value Per Share--0.1900.108+76%0.029+563%-0.172+191%-0.128+167%
Current Ratio--3.3962.194+55%1.424+138%1.728+96%1.301+161%
Debt To Asset Ratio--0.7290.858-15%0.957-24%1.733-58%1.283-43%
Debt To Equity Ratio--2.6886.380-58%5.066-47%3.802-29%2.817-5%
Dividend Per Share----0%0.004-100%0.001-100%0.001-100%
Enterprise Value--216926880.000182165629.600+19%202077434.080+7%733550859.940-70%733550859.940-70%
Eps---0.070-0.075+7%-0.100+42%-0.079+13%-0.072+3%
Ev To Ebitda Ratio---7.975-6.605-17%-4.443-44%-37.724+373%-37.724+373%
Ev To Sales Ratio--2.9882.779+8%4.885-39%13.063-77%13.063-77%
Free Cash Flow Per Share---0.075-0.106+41%-0.077+2%-0.069-8%-0.061-19%
Free Cash Flow To Equity Per Share---0.0740.020-470%0.008-1022%0.008-1010%-0.004-95%
Gross Profit Margin--1.0001.519-34%1.433-30%1.883-47%1.907-48%
Intrinsic Value_10Y_max---3.791--------
Intrinsic Value_10Y_min---3.273--------
Intrinsic Value_1Y_max---0.352--------
Intrinsic Value_1Y_min---0.346--------
Intrinsic Value_3Y_max---1.080--------
Intrinsic Value_3Y_min---1.030--------
Intrinsic Value_5Y_max---1.832--------
Intrinsic Value_5Y_min---1.699--------
Market Cap194925790.720-34%260406880.000239662129.600+9%256021934.080+2%621290637.952-58%460215287.372-43%
Net Profit Margin---0.565-0.677+20%-1.654+193%-1.271+125%-1.313+132%
Operating Margin---0.453-0.540+19%-1.199+165%-1.004+122%-1.046+131%
Operating Ratio--1.4731.534-4%2.176-32%1.984-26%2.006-27%
Pb Ratio7.037-33%9.3489.030+4%-28.968+410%12.989-28%9.622-3%
Pe Ratio-4.778+25%-6.346-5.659-11%-4.502-29%-20.108+217%-14.894+135%
Price Per Share1.340-33%1.7801.645+8%1.760+1%4.271-58%3.163-44%
Price To Free Cash Flow Ratio-4.473+25%-5.942-4.152-30%-6.163+4%19.934-130%14.766-140%
Price To Total Gains Ratio-22.769+25%-30.246-0.283-99%2.821-1172%-182.594+504%-182.594+504%
Quick Ratio--3.0431.935+57%1.257+142%1.500+103%1.120+172%
Return On Assets---0.100-0.110+11%-0.200+100%-0.163+63%-0.121+21%
Return On Equity---0.368-0.665+81%-1.265+244%-0.704+91%-0.521+42%
Total Gains Per Share---0.0590.050-217%0.007-941%0.011-656%0.008-850%
Usd Book Value--27857000.00015798750.000+76%4179250.000+567%-25077650.000+190%-18576037.037+167%
Usd Book Value Change Per Share---0.0590.050-217%0.003-2450%0.010-718%0.007-934%
Usd Book Value Per Share--0.1900.108+76%0.029+563%-0.172+191%-0.128+167%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.001-100%
Usd Enterprise Value--216926880.000182165629.600+19%202077434.080+7%733550859.940-70%733550859.940-70%
Usd Eps---0.070-0.075+7%-0.100+42%-0.079+13%-0.072+3%
Usd Free Cash Flow---10957000.000-15399250.000+41%-11145750.000+2%-10060750.000-8%-8838925.926-19%
Usd Free Cash Flow Per Share---0.075-0.106+41%-0.077+2%-0.069-8%-0.061-19%
Usd Free Cash Flow To Equity Per Share---0.0740.020-470%0.008-1022%0.008-1010%-0.004-95%
Usd Market Cap194925790.720-34%260406880.000239662129.600+9%256021934.080+2%621290637.952-58%460215287.372-43%
Usd Price Per Share1.340-33%1.7801.645+8%1.760+1%4.271-58%3.163-44%
Usd Profit---10258000.000-10954750.000+7%-17051750.000+66%-12123250.000+18%-10916111.111+6%
Usd Revenue--18151000.00016390500.000+11%11006750.000+65%12326350.000+47%10526185.185+72%
Usd Total Gains Per Share---0.0590.050-217%0.007-941%0.011-656%0.008-850%
 EOD+3 -5MRQTTM+27 -11YOY+25 -155Y+21 -1910Y+21 -19

3.3 Fundamental Score

Let's check the fundamental score of Biodesix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.778
Price to Book Ratio (EOD)Between0-17.037
Net Profit Margin (MRQ)Greater than0-0.565
Operating Margin (MRQ)Greater than0-0.453
Quick Ratio (MRQ)Greater than13.043
Current Ratio (MRQ)Greater than13.396
Debt to Asset Ratio (MRQ)Less than10.729
Debt to Equity Ratio (MRQ)Less than12.688
Return on Equity (MRQ)Greater than0.15-0.368
Return on Assets (MRQ)Greater than0.05-0.100
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Biodesix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.681
Ma 20Greater thanMa 501.324
Ma 50Greater thanMa 1001.461
Ma 100Greater thanMa 2001.601
OpenGreater thanClose1.290
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biodesix Inc

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Fundamental data was last updated by Penke on 2024-12-05 13:45:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biodesix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -56.5% means that $-0.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biodesix Inc:

  • The MRQ is -56.5%. The company is making a huge loss. -2
  • The TTM is -67.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56.5%TTM-67.7%+11.2%
TTM-67.7%YOY-165.4%+97.6%
TTM-67.7%5Y-127.1%+59.4%
5Y-127.1%10Y-131.3%+4.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.5%-2.6%-53.9%
TTM-67.7%-9.1%-58.6%
YOY-165.4%-0.8%-164.6%
5Y-127.1%-3.0%-124.1%
10Y-131.3%-0.7%-130.6%
4.3.1.2. Return on Assets

Shows how efficient Biodesix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • -10.0% Return on Assets means that Biodesix generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biodesix Inc:

  • The MRQ is -10.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.0%TTM-11.0%+1.1%
TTM-11.0%YOY-20.0%+8.9%
TTM-11.0%5Y-16.3%+5.3%
5Y-16.3%10Y-12.1%-4.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.0%-1.1%-8.9%
TTM-11.0%-1.7%-9.3%
YOY-20.0%-0.9%-19.1%
5Y-16.3%-0.3%-16.0%
10Y-12.1%-0.4%-11.7%
4.3.1.3. Return on Equity

Shows how efficient Biodesix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • -36.8% Return on Equity means Biodesix generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biodesix Inc:

  • The MRQ is -36.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -66.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.8%TTM-66.5%+29.7%
TTM-66.5%YOY-126.5%+60.0%
TTM-66.5%5Y-70.4%+3.9%
5Y-70.4%10Y-52.1%-18.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.8%0.1%-36.9%
TTM-66.5%-2.1%-64.4%
YOY-126.5%0.3%-126.8%
5Y-70.4%-0.9%-69.5%
10Y-52.1%-0.8%-51.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biodesix Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biodesix is operating .

  • Measures how much profit Biodesix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • An Operating Margin of -45.3% means the company generated $-0.45  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biodesix Inc:

  • The MRQ is -45.3%. The company is operating very inefficient. -2
  • The TTM is -54.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-45.3%TTM-54.0%+8.7%
TTM-54.0%YOY-119.9%+65.9%
TTM-54.0%5Y-100.4%+46.4%
5Y-100.4%10Y-104.6%+4.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.3%-12.0%-33.3%
TTM-54.0%-16.5%-37.5%
YOY-119.9%2.5%-122.4%
5Y-100.4%-1.2%-99.2%
10Y-104.6%2.4%-107.0%
4.3.2.2. Operating Ratio

Measures how efficient Biodesix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.47 means that the operating costs are $1.47 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biodesix Inc:

  • The MRQ is 1.473. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.534. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.473TTM1.534-0.060
TTM1.534YOY2.176-0.642
TTM1.5345Y1.984-0.450
5Y1.98410Y2.006-0.022
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4731.230+0.243
TTM1.5341.278+0.256
YOY2.1761.266+0.910
5Y1.9841.206+0.778
10Y2.0061.191+0.815
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biodesix Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biodesix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.40 means the company has $3.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biodesix Inc:

  • The MRQ is 3.396. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.194. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.396TTM2.194+1.202
TTM2.194YOY1.424+0.770
TTM2.1945Y1.728+0.466
5Y1.72810Y1.301+0.427
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3962.116+1.280
TTM2.1942.050+0.144
YOY1.4242.606-1.182
5Y1.7282.646-0.918
10Y1.3013.229-1.928
4.4.3.2. Quick Ratio

Measures if Biodesix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.04 means the company can pay off $3.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biodesix Inc:

  • The MRQ is 3.043. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.935. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.043TTM1.935+1.108
TTM1.935YOY1.257+0.677
TTM1.9355Y1.500+0.434
5Y1.50010Y1.120+0.380
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0431.229+1.814
TTM1.9351.276+0.659
YOY1.2571.742-0.485
5Y1.5002.094-0.594
10Y1.1202.435-1.315
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biodesix Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biodesix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biodesix to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.73 means that Biodesix assets are financed with 72.9% credit (debt) and the remaining percentage (100% - 72.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biodesix Inc:

  • The MRQ is 0.729. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.858. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.729TTM0.858-0.129
TTM0.858YOY0.957-0.099
TTM0.8585Y1.733-0.874
5Y1.73310Y1.283+0.449
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7290.441+0.288
TTM0.8580.441+0.417
YOY0.9570.359+0.598
5Y1.7330.427+1.306
10Y1.2830.443+0.840
4.5.4.2. Debt to Equity Ratio

Measures if Biodesix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biodesix to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 268.8% means that company has $2.69 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biodesix Inc:

  • The MRQ is 2.688. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.380. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.688TTM6.380-3.692
TTM6.380YOY5.066+1.314
TTM6.3805Y3.802+2.578
5Y3.80210Y2.817+0.986
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6880.686+2.002
TTM6.3800.673+5.707
YOY5.0660.502+4.564
5Y3.8020.666+3.136
10Y2.8170.717+2.100
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biodesix generates.

  • Above 15 is considered overpriced but always compare Biodesix to the Diagnostics & Research industry mean.
  • A PE ratio of -6.35 means the investor is paying $-6.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biodesix Inc:

  • The EOD is -4.778. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.346. Based on the earnings, the company is expensive. -2
  • The TTM is -5.659. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.778MRQ-6.346+1.569
MRQ-6.346TTM-5.659-0.687
TTM-5.659YOY-4.502-1.157
TTM-5.6595Y-20.108+14.448
5Y-20.10810Y-14.894-5.213
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.778-0.234-4.544
MRQ-6.346-0.290-6.056
TTM-5.659-0.693-4.966
YOY-4.502-0.065-4.437
5Y-20.1082.176-22.284
10Y-14.8943.735-18.629
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biodesix Inc:

  • The EOD is -4.473. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.942. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.152. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.473MRQ-5.942+1.469
MRQ-5.942TTM-4.152-1.790
TTM-4.152YOY-6.163+2.011
TTM-4.1525Y19.934-24.086
5Y19.93410Y14.766+5.168
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.473-0.583-3.890
MRQ-5.942-1.060-4.882
TTM-4.152-1.060-3.092
YOY-6.163-2.360-3.803
5Y19.934-2.193+22.127
10Y14.766-2.168+16.934
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biodesix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 9.35 means the investor is paying $9.35 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biodesix Inc:

  • The EOD is 7.037. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.348. Based on the equity, the company is overpriced. -1
  • The TTM is 9.030. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.037MRQ9.348-2.311
MRQ9.348TTM9.030+0.318
TTM9.030YOY-28.968+37.998
TTM9.0305Y12.989-3.959
5Y12.98910Y9.622+3.368
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD7.0372.117+4.920
MRQ9.3482.207+7.141
TTM9.0302.192+6.838
YOY-28.9682.258-31.226
5Y12.9893.446+9.543
10Y9.6224.078+5.544
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biodesix Inc.

4.8.1. Institutions holding Biodesix Inc

Institutions are holding 42.829% of the shares of Biodesix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Telemark Asset Management, LLC5.69371.4887828249000
2024-09-30AIGH Capital Management, LLC3.90452.85155679812-100000-1.7302
2024-09-30Birchview Capital, LP3.80928.5531554117600
2024-09-30Farallon Capital Management, L.L.C.3.18750.040446367912758616146.8775
2024-09-30Sio Capital Management, LLC2.98253.06244338514-9341-0.2148
2024-09-30Soleus Capital Management, L.P.2.77590.55664038065-2073899-33.9318
2024-09-30Opaleye Management Inc2.62261.16263815000-205000-5.0995
2024-09-30SILVERARC CAPITAL MANAGEMENT, LLC2.4481.42353561094175213596.8587
2024-09-30Monashee Investment Management LLC2.40660.674835008792400007.36
2024-09-30Vanguard Group Inc2.03670.00012962690561861.9331
2024-09-30Perceptive Advisors LLC1.49440.0819217388000
2024-09-30Essex Investment Management Company, LLC0.66760.301397119725800.2664
2024-09-30Wells Fargo & Co0.63540.0004924233-6948-0.7461
2024-09-30Geode Capital Management, LLC0.55310.000180457627072450.7114
2024-09-30Perkins Capital Management Inc0.49821.209872478231000074.7381
2024-09-30AMH Equity Ltd0.47851.571969607300
2024-06-30BlackRock Inc0.28590415908130003.2265
2024-09-30Legato Capital Management LLC0.22980.073633431000
2024-09-30State Street Corp0.1984028855000
2024-09-30Bridgeway Capital Management, LLC0.19560.0112845119944853.7374
Total 37.104123.063753974531+3107501+5.8%

4.9.2. Funds holding Biodesix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv1.57910.0002229711286100059.9535
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.97530.0022141867400
2024-09-30Fidelity Extended Market Index0.28950.00184210967422621.3988
2024-09-30Bridgeway Ultra-Small Company Market0.18990.28092763119944856.2288
2024-09-301290 Essex Small Cap Growth I0.12240.494517808700
2024-09-30Pleiades Small Cap Equity A0.0960.024413970600
2024-09-30Fidelity Total Market Index0.0930.00021352235039359.4047
2024-09-30BlackRock Extended Equity Market K0.09050.00161316381316380
2024-09-30Fidelity Series Total Market Index0.0670.00029742462765181.0929
2024-11-27iShares Micro-Cap ETF0.05020.01047296300
2024-09-30Spartan Total Market Index Pool E0.04110.00035974243716272.7817
2024-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03880.00035649700
2024-09-30Vanguard Instl Ttl Stck Mkt Idx Tr0.03880.000356497564970
2024-09-30Fidelity Nasdaq Composite Index0.03860.00065608400
2024-09-30Spartan Extended Market Index Pool E0.02370.0014344091180652.232
2024-10-31Vanguard Balanced Index Inv0.02080.00013032200
2024-09-30Northern Trust Extended Eq Market Idx0.02040.00072972400
2024-09-30NT Ext Equity Mkt Idx Fd - L0.02040.00072972400
2024-06-30Essex Inv Mgt Micro Cap Growth0.01580.78412293100
2024-10-31Vanguard U.S. Eq Idx £ Acc0.01450.00022108500
Total 3.82581.60515565249+1391489+25.0%

5.3. Insider Transactions

Insiders are holding 48.618% of the shares of Biodesix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-20Jack W SchulerBUY2000001.17
2024-11-05John PatienceBUY750001.38
2024-11-05Matthew StrobeckBUY400001.4
2024-08-12Chris VazquezSELL541.57
2024-08-12Gary Anthony PestanoSELL1111.57
2024-08-12Robin Harper CowieSELL2511.57
2024-08-12Scott HuttonSELL9631.57
2024-08-09Chris VazquezSELL1551.6
2024-08-09Gary Anthony PestanoSELL3201.6
2024-08-09Robin Harper CowieSELL7241.6
2024-08-09Scott HuttonSELL27811.6
2024-05-09Chris VazquezSELL2441.48
2024-05-09Scott HuttonSELL37641.48
2024-05-09Robin Harper CowieSELL9801.48
2024-05-09Gary Anthony PestanoSELL4341.48
2024-02-12Chris VazquezSELL9221.66
2024-02-12Gary Anthony PestanoSELL50221.66
2024-02-12Robin Harper CowieSELL86991.66
2024-02-12Scott HuttonSELL297081.66
2024-02-09Chris VazquezSELL10771.92
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets102,743
Total Liabilities74,886
Total Stockholder Equity27,857
 As reported
Total Liabilities 74,886
Total Stockholder Equity+ 27,857
Total Assets = 102,743

Assets

Total Assets102,743
Total Current Assets44,017
Long-term Assets58,726
Total Current Assets
Cash And Cash Equivalents 31,406
Net Receivables 8,036
Other Current Assets 4,575
Total Current Assets  (as reported)44,017
Total Current Assets  (calculated)44,017
+/-0
Long-term Assets
Property Plant Equipment 30,601
Goodwill 15,031
Intangible Assets 6,438
Long-term Assets Other 6,656
Long-term Assets  (as reported)58,726
Long-term Assets  (calculated)58,726
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,963
Long-term Liabilities61,923
Total Stockholder Equity27,857
Total Current Liabilities
Short-term Debt 1,277
Accounts payable 2,537
Other Current Liabilities 8,473
Total Current Liabilities  (as reported)12,963
Total Current Liabilities  (calculated)12,287
+/- 676
Long-term Liabilities
Long-term Liabilities  (as reported)61,923
Long-term Liabilities  (calculated)0
+/- 61,923
Total Stockholder Equity
Common Stock145
Retained Earnings -454,246
Other Stockholders Equity 481,958
Total Stockholder Equity (as reported)27,857
Total Stockholder Equity (calculated)27,857
+/-0
Other
Cash and Short Term Investments 31,406
Common Stock Shares Outstanding 146,296
Current Deferred Revenue676
Liabilities and Stockholders Equity 102,743
Net Debt 30,550
Net Working Capital 31,054
Short Long Term Debt Total 61,956



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
> Total Assets 
0
0
0
0
0
0
0
41,633
0
45,478
46,547
121,070
115,486
101,804
89,997
76,097
61,651
75,229
63,198
92,906
80,793
77,623
86,786
99,096
87,201
115,841
102,743
102,743115,84187,20199,09686,78677,62380,79392,90663,19875,22961,65176,09789,997101,804115,486121,07046,54745,478041,6330000000
   > Total Current Assets 
0
0
0
0
0
0
12,700
12,700
17,618
17,618
18,149
86,140
81,244
68,450
56,445
43,613
27,233
35,057
24,118
53,334
34,784
25,245
28,886
39,683
28,479
57,579
44,017
44,01757,57928,47939,68328,88625,24534,78453,33424,11835,05727,23343,61356,44568,45081,24486,14018,14917,61817,61812,70012,700000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
5,286
0
11,674
6,348
62,126
55,329
56,349
47,913
32,712
16,427
23,586
15,175
43,088
25,275
17,409
19,841
26,384
11,591
42,319
31,406
31,40642,31911,59126,38419,84117,40925,27543,08815,17523,58616,42732,71247,91356,34955,32962,1266,34811,67405,2860000000
       Net Receivables 
0
0
0
0
0
0
5,292
5,292
2,946
2,946
5,396
15,304
18,367
5,281
2,784
3,656
3,774
5,452
4,449
5,065
4,901
4,119
5,777
7,679
9,893
10,128
8,036
8,03610,1289,8937,6795,7774,1194,9015,0654,4495,4523,7743,6562,7845,28118,36715,3045,3962,9462,9465,2925,292000000
       Other Current Assets 
0
0
0
0
0
0
1,322
2,122
1,198
2,998
6,405
8,710
7,548
6,820
5,748
7,245
7,032
6,019
4,494
5,181
4,608
3,717
3,268
4,320
5,695
4,032
4,575
4,5754,0325,6954,3203,2683,7174,6085,1814,4946,0197,0327,2455,7486,8207,5488,7106,4052,9981,1982,1221,322000000
   > Long-term Assets 
0
0
0
0
0
0
0
28,933
0
27,860
28,398
34,930
34,242
33,354
33,552
32,484
34,418
40,172
39,080
39,572
46,009
52,378
57,900
59,413
58,722
58,262
58,726
58,72658,26258,72259,41357,90052,37846,00939,57239,08040,17234,41832,48433,55233,35434,24234,93028,39827,860028,9330000000
       Property Plant Equipment 
0
0
0
0
0
0
2,120
2,120
1,994
1,994
3,005
3,178
3,387
3,378
4,432
4,179
6,247
7,902
7,734
8,821
15,291
21,488
27,488
29,612
30,132
29,786
30,601
30,60129,78630,13229,61227,48821,48815,2918,8217,7347,9026,2474,1794,4323,3783,3873,1783,0051,9941,9942,1202,120000000
       Goodwill 
0
0
0
0
0
0
0
11,631
0
11,631
11,631
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,031
15,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03115,03111,63111,631011,6310000000
       Intangible Assets 
0
0
0
0
0
0
0
15,092
0
14,145
13,667
13,260
12,821
12,400
11,992
11,617
11,131
10,688
10,223
9,797
9,311
8,871
8,416
7,911
7,384
6,884
6,438
6,4386,8847,3847,9118,4168,8719,3119,79710,22310,68811,13111,61711,99212,40012,82113,26013,66714,145015,0920000000
       Other Assets 
0
0
0
0
0
0
90
90
90
90
95
3,461
3,003
2,545
2,097
1,657
2,009
6,551
6,092
5,923
0
6,988
0
0
0
0
0
000006,98805,9236,0926,5512,0091,6572,0972,5453,0033,4619590909090000000
> Total Liabilities 
0
0
0
0
0
0
0
270,172
0
66,369
301,723
79,904
79,054
76,031
73,964
56,370
53,870
67,558
66,101
72,300
76,243
84,616
88,232
94,516
92,703
79,581
74,886
74,88679,58192,70394,51688,23284,61676,24372,30066,10167,55853,87056,37073,96476,03179,05479,904301,72366,3690270,1720000000
   > Total Current Liabilities 
0
0
0
0
0
0
22,600
22,600
45,047
13,770
56,563
32,125
16,124
21,272
22,787
28,960
29,811
33,074
37,415
22,839
22,098
27,951
32,649
33,416
31,230
17,552
12,963
12,96317,55231,23033,41632,64927,95122,09822,83937,41533,07429,81128,96022,78721,27216,12432,12556,56313,77045,04722,60022,600000000
       Short-term Debt 
0
0
0
0
0
0
0
12,159
0
4,064
33,802
11,840
2,707
3,106
20
19
1,161
13,086
15,770
1,592
1,812
1,554
1,163
555
317
637
1,277
1,2776373175551,1631,5541,8121,59215,77013,0861,16119203,1062,70711,84033,8024,064012,1590000000
       Short Long Term Debt 
0
0
0
0
0
0
0
12,159
0
4,064
33,802
11,840
2,707
3,106
20
19
51
11,771
14,334
49
50
50
50
51
45
37
0
03745515050504914,33411,7715119203,1062,70711,84033,8024,064012,1590000000
       Accounts payable 
0
0
0
0
0
0
1,717
1,717
948
948
3,485
8,964
3,747
1,160
1,600
1,662
2,120
1,791
2,100
1,685
1,563
3,501
2,904
2,929
3,213
2,220
2,537
2,5372,2203,2132,9292,9043,5011,5631,6852,1001,7912,1201,6621,6001,1603,7478,9643,4859489481,7171,717000000
       Other Current Liabilities 
0
0
0
0
0
0
4,587
7,441
11,036
4,323
13,603
7,789
7,262
14,824
19,407
25,429
24,031
15,967
17,908
18,600
17,590
21,827
27,923
29,608
27,387
14,248
8,473
8,47314,24827,38729,60827,92321,82717,59018,60017,90815,96724,03125,42919,40714,8247,2627,78913,6034,32311,0367,4414,587000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
247,572
0
52,599
245,160
47,779
62,930
54,759
51,177
27,410
24,059
34,484
28,686
49,461
54,145
56,665
55,583
61,100
61,473
62,029
61,923
61,92362,02961,47361,10055,58356,66554,14549,46128,68634,48424,05927,41051,17754,75962,93047,779245,16052,5990247,5720000000
       Other Liabilities 
0
0
0
0
0
0
29,801
29,801
32,753
32,753
30,866
31,853
32,602
24,804
21,202
17,417
12,827
22,986
20,951
19,203
0
13,199
0
0
0
0
0
0000013,199019,20320,95122,98612,82717,41721,20224,80432,60231,85330,86632,75332,75329,80129,801000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
654
0
654
0
0
0
0
0
0000065406540000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
-228,539
0
-20,891
-255,176
41,166
36,432
25,773
16,033
19,727
7,781
7,671
-2,903
20,606
4,550
-6,993
-1,446
4,580
-5,502
36,260
27,857
27,85736,260-5,5024,580-1,446-6,9934,55020,606-2,9037,6717,78119,72716,03325,77336,43241,166-255,176-20,8910-228,5390000000
   Common Stock
0
0
0
0
0
0
1
1
2
22
2
27
27
27
27
31
32
40
41
78
78
79
88
96
97
145
145
1451459796887978784140323127272727222211000000
   Retained Earnings Total Equity000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-6,386
0
-6,415
63,722
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000063,722-6,4150-6,3860000000
   Capital Surplus 000000000000000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
2,324
0
236,066
-255,178
299,953
302,180
302,923
304,697
321,669
325,308
341,014
344,138
387,948
390,594
392,406
408,893
424,050
427,581
480,103
481,958
481,958480,103427,581424,050408,893392,406390,594387,948344,138341,014325,308321,669304,697302,923302,180299,953-255,178236,06602,3240000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue49,087
Cost of Revenue-13,010
Gross Profit36,07736,077
 
Operating Income (+$)
Gross Profit36,077
Operating Expense-77,419
Operating Income-41,342-41,342
 
Operating Expense (+$)
Research Development9,988
Selling General Administrative67,762
Selling And Marketing Expenses0
Operating Expense77,41977,750
 
Net Interest Income (+$)
Interest Income0
Interest Expense-9,536
Other Finance Cost-221
Net Interest Income-9,757
 
Pretax Income (+$)
Operating Income-41,342
Net Interest Income-9,757
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-52,146-30,538
EBIT - interestExpense = -52,146
-46,807
-42,610
Interest Expense9,536
Earnings Before Interest and Taxes (EBIT)-42,610-42,610
Earnings Before Interest and Taxes (EBITDA)-37,103
 
After tax Income (+$)
Income Before Tax-52,146
Tax Provision-0
Net Income From Continuing Ops-63,345-52,146
Net Income-52,146
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses90,429
Total Other Income/Expenses Net-10,8049,757
 

Technical Analysis of Biodesix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biodesix. The general trend of Biodesix is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biodesix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biodesix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.455 < 1.455 < 1.4714.

The bearish price targets are: 1.215 > 1.15 > 1.11.

Tweet this
Biodesix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biodesix Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biodesix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biodesix Inc. The current macd is -0.03425152.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biodesix price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biodesix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biodesix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biodesix Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiodesix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biodesix Inc. The current adx is 31.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biodesix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biodesix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biodesix Inc. The current sar is 1.24.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biodesix Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biodesix Inc. The current rsi is 46.68. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biodesix Inc Daily Relative Strength Index (RSI) ChartBiodesix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biodesix Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biodesix price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biodesix Inc Daily Stochastic Oscillator ChartBiodesix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biodesix Inc. The current cci is 8.80445832.

Biodesix Inc Daily Commodity Channel Index (CCI) ChartBiodesix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biodesix Inc. The current cmo is -1.20983857.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biodesix Inc Daily Chande Momentum Oscillator (CMO) ChartBiodesix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biodesix Inc. The current willr is -56.14035088.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biodesix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biodesix Inc Daily Williams %R ChartBiodesix Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biodesix Inc.

Biodesix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biodesix Inc. The current atr is 0.09884818.

Biodesix Inc Daily Average True Range (ATR) ChartBiodesix Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biodesix Inc. The current obv is 1,477,165.

Biodesix Inc Daily On-Balance Volume (OBV) ChartBiodesix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biodesix Inc. The current mfi is 56.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biodesix Inc Daily Money Flow Index (MFI) ChartBiodesix Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biodesix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biodesix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biodesix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.681
Ma 20Greater thanMa 501.324
Ma 50Greater thanMa 1001.461
Ma 100Greater thanMa 2001.601
OpenGreater thanClose1.290
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biodesix with someone you think should read this too:
  • Are you bullish or bearish on Biodesix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biodesix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biodesix Inc

I send you an email if I find something interesting about Biodesix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biodesix Inc.

Receive notifications about Biodesix Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.